- Report
- February 2024
- 77 Pages
Global
From €3500EUR$4,057USD£3,048GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$4,057USD£3,048GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,057USD£3,048GBP
- Report
- February 2024
- 85 Pages
Global
From €3500EUR$4,057USD£3,048GBP
- Report
- January 2024
- 78 Pages
Global
From €3500EUR$4,057USD£3,048GBP
- Report
- July 2023
- 90 Pages
Global
From €3500EUR$4,057USD£3,048GBP
- Report
- May 2023
- 109 Pages
Global
From €3500EUR$4,057USD£3,048GBP
- Report
- April 2023
- 147 Pages
Global
From €4573EUR$4,949USD£3,848GBP
- Report
- February 2022
- 106 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Drug Pipelines
- October 2020
- 170 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Report
- July 2022
- 85 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Report
- June 2022
- 43 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Report
- June 2022
- 43 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Report
- May 2022
- 56 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Report
- May 2022
- 65 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Report
- May 2022
- 35 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Drug Pipelines
- June 2021
- 847 Pages
Global
From €2310EUR$2,500USD£1,944GBP
- Drug Pipelines
- June 2020
- 139 Pages
Global
From €1848EUR$2,000USD£1,555GBP
- Clinical Trials
- April 2024
- 390 Pages
Global
From €2310EUR$2,500USD£1,944GBP
- Clinical Trials
- March 2024
- 1168 Pages
Global
From €2310EUR$2,500USD£1,944GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more